Trailing-twelve-month (TTM) revenue is $271.67 Million with a year-over-year growth of +562.91%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $64,220,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $78,321,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-27 |
| Q1 FY2026Period ended 2026-03-31 | $62,118,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $67,015,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $271,674,000 |
Current P/S: $630,561,453 market capitalization ÷ $271,674,000 TTM revenue = 2.32x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:15:20.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $67.02M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:15:31.850Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD |
|---|---|---|
| Consulting Revenues | $2M | $682,309 |
| Other Revenues | $176,152 | $42,074 |
| Software Revenues | $19M | $13M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Canada | $3M | N/A |
| CANADA | N/A | $2M |
| United States | $10M | N/A |
| UNITED STATES | N/A | $183M |
$271.67M
$271.67 Million
+562.91%
vs. $40.98M a year ago (TTM)
+74.61%
5 Year compound annual growth rate
1 Year
+562.91%
3 Year
+155.54%
5 Year
+74.61%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $185.16M | +$113.63M | +158.84% |
| 2024 | $71.54M | +$6.56M | +10.09% |
| 2023 | $64.98M | ($720,000) | (1.10%) |
| 2022 | $65.70M | +$48.07M | +272.73% |
| 2021 | $17.63M | +$1.98M | +12.64% |
| 2020 |
TTM Growth
+562.91%
3-Year CAGR
+155.54%
5-Year CAGR
+74.61%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $15.65M |
| +$4.73M |
| +43.31% |
